EPLAW PATENT BLOG

UK – AIM Sport Vision v. Supponor

Posted: February 9th, 2023

AIM Sport Vision AG v Supponor Limited and Supponor Oy [2023] EWHC 164 (Pat) The English High Court has held that AIM’s patent concerning virtual advertising billboards (EP (UK) 3 295 663 B1 (“the Patent”)) is both valid and infringed by Supponor’s competing technology. These advertising billboards are used in sports stadiums and relate to […]

READ MORE

NL – Tinnus Enterprises v. [x] International / appeal

Posted: October 11th, 2022

Tinnus Enterprises LLC and Zuru Inc. v. [x] International, Court of Appeal The Hague, The Netherlands, 20 September 2022, Case no. ECLI:NL:GHDHA:2022:1802 Tinnus holds EP 3 005 948 B1 (hereinafter: EP 948 or the patent). EP 948, entitled ‘Apparatus, system and method for filling containers with fluids’ is licensed to Zuru which markets a toy […]

READ MORE

UK – BMS/Pfizer v. Sandoz/Teva

Posted: July 23rd, 2022

Sandoz Limited v Bristol-Myers Squibb Holdings Ireland Unlimited Company and Pfizer Inc. heard together with Teva Pharmaceutical Industries Limited v Bristol-Myers Squibb Holdings Ireland Unlimited Company and Pfizer Inc. v Teva UK Limited (Part 20 Defendant), High Court, London, UK, 15 July 2022, [2022] EWHC 1831 (Pat) Bristol-Myers Squibb and Pfizer’s formulation patents protecting formulations […]

READ MORE

NL – Novartis v. Mylan

Posted: July 12th, 2022

In an interim relief decision of 21 June 2022, the preliminary injunction (PI) Judge of the District Court of The Hague held Novartis’ EP 2 959 894 (“EP 894”) re fingolimod 0,5 mg provisionally invalid. This is the first substantive PI decision on the validity of EP 894 matter in Europe, where several proceedings between […]

READ MORE

UK – Alcon Research v. Pharmathen and Aspire Pharma

Posted: July 7th, 2022

Alcon Research LLC and another v Pharmathen SA and Aspire Pharma Limited, Court of Appeal, London, UK, 28 June 2022, [2022] EWCA Civ 845 The English Court of Appeal (Lord Justice Arnold giving the leading judgment with whom Lady Justice King and Lord Justice Nugee agreed) has rejected an appeal by Aspire Pharma Limited (“Aspire”) […]

READ MORE

UK – Teva & Sandoz v. Astellas

Posted: July 6th, 2022

Overview In two actions that were heard together, Teva and Sandoz (‘the Claimants’) sought revocation of Astellas’ patent EP (UK) 1 559 427 B1 (‘the Patent’). The patent relates to a compound mirabegron (sold under the name Betmiga) which is used to treat overactive bladder (OAB). Mirabegron is a β3 adrenoreceptor (“β3-AR”) agonist. Astellas counterclaimed […]

READ MORE

UK – Optis v. Apple

Posted: March 30th, 2022

Judgment handed down in the last of the technical trials in Optis v Apple saga: Optis succeeds in arguing that its patents are valid and infringed by Apple Overview The 15 March 2022 judgment of Mr Justice Meade is the latest in the Optis v Apple saga. It is the last in the series of […]

READ MORE

ES – ERASMUS and INVIVO v. VITRO et al.

Posted: November 29th, 2021

Erasmus MC and Invivo v. Vitro et al., Court of Appeals of Barcelona, 8 April 2021, Appeal Docket No. 1969/2020 On 8 April 2021, the Court of Appeals of Barcelona rendered judgment on appeal in a complex case relating to nucleic acid amplification primers for PCR-based clonality studies, involving a number of issues regarding the […]

READ MORE

NL – Nutrition v. Noba / Appeal

Posted: November 18th, 2021

Nutrition Sciences N.V. v. Kuminda N B.V., Court of Appeal, The Hague, The Netherlands, 29 June 2021, Case no. ECLI:NL:GHDHA:2021:2055 Nutrition is active in the field of ingredients for live stock feed and alleged that Noba infringes on the Dutch part of its EP 1 294 371 B2 relating to “medium chain fatty acids applicable […]

READ MORE